logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure GPS-18. Overview of drug prevalence estimates from various studies in Europe for all adults (aged 15 to 64) and young adults (aged 15 to 34) [see all figures in this series...]

Part (ii) Cocaine, amphetamines and ecstasy use — lifetime experience, last year and last month prevalence


The chart shows the overall average of the relevant studies, weighted by sample size.

Related links:

Statistical bulletin 2006: Figure GPS-33 part (ii)
Statistical bulletin 2007: Figure GPS-18 part (ii)

See also Table GPS-0

For details of the studies included see Tables GPS-1 to GPS-6

See also 'General notes for interpreting data' on the Explanatory notes and help page


Reitox national reports 2007, taken from population surveys, reports or scientific articles.

(see the help page for information about formats etc.)

Page last updated: Wednesday, 16 July 2008